Trenor Cameron C. III bought ANTX
September 15, 2026 · Form 4 insider transaction
Trenor Cameron C. III bought 233,333 shares of AN2 Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
233,333
Price
$0.00
Total value
N/A
InsiderTrenor Cameron C. III
RoleOfficer
SecurityStock Option (right to by)
Transaction codeA: Grant or award
Transaction dateSeptember 15, 2026
Filing dateSeptember 16, 2026
Shares owned after233,333
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares subject to the stock option vest as follows: 25% of the shares vest on August 24, 2027 and the remaining shares vest in equal monthly installments over the subsequent 36 months, subject to the Reporting Person's continuous service through each applicable vesting date.